CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast
Yunjeong Jang, Hera Jung, Han-Na Kim, Youjeong Seo, Emad Alsharif, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Yeon Hee Park, Eun Yoon Cho, Soo Youn Cho
JPTM. 2020;54(1):95-102.   Published online 2019 November 13    DOI: https://doi.org/10.4132/jptm.2019.10.24

Excel Download

Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast
Journal of Pathology and Translational Medicine. 2020;54(1):95-102   Crossref logo
Link1 Link2 Link3

Resistance to Trastuzumab in HER2-Positive Mucinous Invasive Ductal Breast Carcinoma
Clinical Breast Cancer. 2013;13(2):156-158   Crossref logo
Link1 Link2

Pure mucinous carcinoma of the breast: A clinicopathologic correlation study
Annals of Surgical Oncology. 1998;5(5):447-451   Crossref logo
Link1 Link2 Link3

HER2-Positive Breast Cancer
Her2-Positive Breast Cancer. 2019;63-74   Crossref logo
Link1 Link2

Biosimilars for HER2-Positive Breast Cancer
Her2-Positive Breast Cancer. 2019;231-237   Crossref logo
Link1 Link2

Mucinous Carcinoma of the Breast in Comparison with Invasive Ductal Carcinoma: Clinicopathologic Characteristics and Prognosis
Journal of Breast Cancer. 2011;14(4):308   Crossref logo
Link1 Link2 Link3

Pure and mixed mucinous carcinoma of the breast: fine needle aspiration cytology findings and review of the literature
Cytopathology. 2012;24(6):377-384   Crossref logo
Link1

Frequency, Clinicopathologic Characteristics, and Follow-up of HER2-Positive Nonpleomorphic Invasive Lobular Carcinoma of the Breast
American Journal of Clinical Pathology. 2019;   Crossref logo
Link1 Link2

Optimal First-Line Treatment of Advanced HER2-Positive Breast Cancer
Her2-Positive Breast Cancer. 2019;41-62   Crossref logo
Link1 Link2

Deescalating Treatment in the Adjuvant Setting in Low-Risk HER2-Positive Breast Cancer
Her2-Positive Breast Cancer. 2019;135-142   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. J Pathol Transl Med has participated in CrossRef Text and Data Mining service since January 16, 2015.